ZOLL Medical
secondary
anchor-links
3
#outline
Corporate Profile
#officer
Officers
#others
Learn about other companies
spacer

Corporate Profile##outline

ZOLL provides a comprehensive portfolio of medical devices and software solutions that diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. ZOLL became a member of the Asahi Kasei Group in April 2012 and is a global leader in acute critical care and related software and diagnostic tools. Through synergy with the other Healthcare businesses of Asahi Kasei, ZOLL helps advance emergency care and save lives, while increasing clinical and operational efficiencies.

ZOLL Products

Contact Us

spacer
column-header
Trade namme
ZOLL Medical Corp.
https://www.zoll.com/
Main businesses
Developing and marketing medical devices and software solutions for defibrillation and
cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy,
data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment
Home office
269 Mill Rd., Chelmsford, MA 01824-4105 USA
CEO
Eric L. Knudsen
Paid-in capital
US$1,723 million (including capital surplus)
Shareholder
Asahi Kasei Holdings US, Inc.*
Phone
+1-978-421-9655

(as of April 1, 2026​)

  • Wholly owned subsidiary of Asahi Kasei Corp.
1

Officers & Directors##officer

column-header
Jonathan A. Rennert
Chairman, Board Director
Eric L. Knudsen
Chief Executive Officer, Board Director
Ken Shinomiya
Board Director
Elijah A. White
Executive Officer
President, ZOLL Acute Care Technology
Michael G. Blastick
Executive Officer
President, ZOLL Cardiac Management Solutions
Collin S. Anderson
Executive Officer
President, ZOLL Respicardia
Craig M. Stowell
Executive Officer
Chief Financial Officer
Lynn A. Hersey
Executive Officer
Vice President, Corporate Human Resources and Services
Jennifer R. Landis
Executive Officer
Vice President, Corporate Development and Stategy

(as of April 1, 2026)

spacer